Clinical significance of salivary, serum, nitric oxide, and arginase in breast cancer

Background: Breast cancer is the most commonly diagnosed among females. A source of sampling for clinical diagnosis saliva which has been utilized and it a promising approach as collecting relatively easy non-invasive. Over past two decades, utilizing biomarker, specifically early attracted much research interest. Aim: To alter sample collection from blood to some components such nitric oxide (NO) arginase, in order detect an easy, earlier noninvasive diagnostic test biomarkers prognostic tools patients with breast cancer. Methods: total 73 female volunteers were participated this study, 25 healthy compared 48 estimate compare both salivary level NO arginase. Results: The mean samples arginase levels significantly raised when they controls (p<0.001). Conclusions: In study changing may be used non-invasive tool alternative serum testing component, increased also, tumor progression tests diagnosing